72% and 36% reduction in the risk of disease progression or death observed in the dMMR/MSI-H population and overall patient population, respectively Clinically meaningful overall survival trend observed at interim analysis Results presented in same-day presentations at ESMO Virtual…

L’APDS (syndrome de la phosphoinositide 3-kinase delta activée (PI3Kδ)) est une immunodéficience primaire rare et progressive Joenja® est un traitement ciblé de l’APDS pour les patients adultes et pédiatriques de 12 ans et plus Joenja® devrait être lancé aux États-Unis début avril…

SHANGHAI, March 27, 2023 /PRNewswire/ — Noah Holdings Limited (“Noah” or the “Company”) (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider in China offering comprehensive one-stop advisory services on global investment and asset allocation primarily for…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.